Page 582 - Cote clinical veterinary advisor dogs and cats 4th
P. 582

264   Dilated Cardiomyopathy


           Clinical Presentation                ○   Sudden cardiac death: presumptive   ○   Occult DCM: often unremarkable (poor
           DISEASE FORMS/SUBTYPES                 malignant ventricular arrhythmias  •  ECG
                                                                                     screening tool)
  VetBooks.ir  dysfunction and/or ventricular dilation based    DIAGNOSIS          ○   Normal sinus rhythm does not rule out
           •  Occult DCM: asymptomatic with systolic
            on echocardiography and/or the presence of
                                                                                     presence of ventricular or atrial arrhyth-
            ventricular arrhythmias.
                                              •  Diagnosis includes disease confirmation in
           •  Symptomatic                     Diagnostic Overview                    mias and does not rule out DCM. May
                                                                                     note atrial premature contractions (APCs),
            ○   Arrhythmias                     animals with clinical abnormalities and diag-  VPCs,  atrial  fibrillation,  ventricular
                 Ventricular arrhythmias (most common   nostic screening in well dogs of commonly   tachycardia
              ■
                in boxers, Doberman pinschers)  affected breeds; well cats are not routinely   ○   One  VPC  on  a  5-min  ECG  strongly
                 Atrial fibrillation (most common in the   screened for DCM.         warrants further examination for DCM
              ■
                giant breeds)                 •  Echocardiography is the current standard   in Doberman pinschers.
            ○   CHF: left  > right sided; biventricular   for diagnosis of systolic dysfunction, with   •  Effusion analysis
              possible                          or without dilation. DCM also causes ven-  ○   Modified transudate consistent with CHF
            ○   Sudden cardiac death (first sign in 35%   tricular arrhythmias that can result in sudden   (nucleated cell count < 2500/mcL, total
              of dogs)                          cardiac death. Gold  standard  screening   protein  <  4.0 g/dL);  chylous  effusion
                                                includes an echocardiogram (p. 1094) and   possible
           HISTORY, CHIEF COMPLAINT             Holter monitoring (24-hour ECG) (p. 1120).  ○   Biventricular heart failure or severe
           •  Occult  DCM:  asymptomatic,  diagnosed   •  Radiographs are indicated for patients with   tachyarrhythmias  (e.g., atrial fibrilla-
            during screening examination or incidental   clinical signs referable to the respiratory   tion) may cause pleural and abdominal
            finding                             system (tachypnea, dyspnea). CHF should   effusion.
           •  Cardiac  arrhythmias:  lethargy,  collapse/  be considered if left atrial and/or ventricular   ○   Presence of only pleural effusion is unusual
            syncope, weakness, precipitation of CHF   enlargement, pulmonary venous congestion,   presentation for CHF.
            (e.g., atrial fibrillation)         and/or pulmonary edema are noted.  •  Echocardiogram:  required  for  definitive
           •  CHF:  dyspnea,  tachypnea,  coughing,                                diagnosis of DCM; not required for initiating
            abdominal distention (biventricular failure   Differential Diagnosis   therapy
            or arrhythmia induced), lethargy, restlessness,   •  Respiratory distress (p. 1219)
            weight loss                       •  Collapse (p. 192)               Advanced or Confirmatory Testing
                                              •  Pleural or abdominal effusion (pp. 79 and   •  Echocardiogram: ventricular and atrial dila-
           PHYSICAL EXAM FINDINGS               791)                               tion (left > right), reduced myocardial systolic
           •  Auscultation: soft murmur 1/6 to 3/6 left                            function (decreased fractional shortening [%]
            or right apical systolic, gallop heart sound,   Initial Database       and ejection fraction [%])
            arrhythmia                        •  Echocardiogram (see Advanced or Confirma-  ○   LV internal diameter in diastole: > 49 mm;
           •  Pulses:  hypokinetic  femoral  pulses,  pulse   tory Testing)          > 99% specific for DCM in Dobermans
            deficits with premature beats or atrial   •  Holter monitor (see Advanced or Confirma-  ○   LV internal diameter in systole: > 40 mm;
            fibrillation                        tory Testing)                        > 99% specific for DCM in Dobermans
                                                                                                                2
           •  Findings  in  CHF:  tachypnea,  weakness,   •  +/− N-terminal pro-B-type natriuretic   ○   End-diastolic volume index > 95 mL/m ;
            cachexia, pale/cyanotic mucous membranes  peptide (NT-pro-BNP)           96% specific for DCM in Dobermans
                                                                                                                2
            ○   Left-sided CHF: pulmonary crackles/rales,   ○   >500 pmol/L:  echocardiogram  recom-  ○   End-systolic volume index > 55 mL/m ;
              muffled lung sounds with pleural effusion  mended                      94% specific for DCM in Dobermans
            ○   Right-sided CHF: abdominal distention,   •  Screening recommendations vary by breed.  ○   Doppler: functional mitral regurgitation
              jugular pulses/distention, muffled heart and   ○   Doberman pinschers: for breeding animals,   common
              lung sounds with pleural effusion, ventral   yearly  echocardiography  and  24-hour   •  Holter monitoring
              subcutaneous (pitting) edema (rare)  Holter monitoring is recommended.  ○   Diagnostic for DCM in Dobermans
                                                  ■   Prevalence increases with age  ■   >100 VPCs/24 hours
           Etiology and Pathophysiology           ■   Ventricular  premature  complexes   ■   >50 VPCs/24 hours on two consecutive
           •  Causes of DCM                        (VPCs):  only  abnormality  noted  in   Holters 6 months apart
            ○   Inherited cardiomyopathy (in many   37% of occult DCM cases      •  Additional case-specific testing
              breeds, DCM that was previously thought   Diagnosis of symptomatic animals:  ○   Taurine concentration
              to be idiopathic has been recognized to   •  CBC usually normal        ■   Deficiency if < 45-50 nmol/mL (plasma)
              have a genetic influence)       •  Biochemistry panel: usually normal    or < 250 nmol/mL (whole blood)
            ○   Infectious myocarditis          ○   Decreased total protein: if presence of large   ○   Cardiac troponin I
            ○   Nutritional deficiency            volume effusion (pleural or abdominal)  ■   >0.34 ng/mL in combination with LV
            ○   Toxicity: doxorubicin cardiotoxicity  ○   Prerenal azotemia from poor cardiac perfusion  enlargement suggests an increased risk
            ○   Other: tachycardia induced, hypothyroidism  ○   Elevated alanine aminotransferase (ALT):   of sudden cardiac death
            ○   Idiopathic: an underlying cause is not   mild, if present          ○   Infectious disease testing (e.g., Chagas
              identified                        ○   Electrolytes: especially important in   titer, Lyme titer)
           •  Primary  myocardial  systolic  dysfunction   patients with arrhythmias. In particular,
            leads to reduced cardiac output, followed   hypokalemia and/or hypomagnesemia    TREATMENT
            by activation of various neurohormonal   can exacerbate arrhythmias and/or reduce
            and cytokine pathways to support blood   efficacy of antiarrhythmic agents.  Treatment Overview
            pressure  (BP)  and  organ  perfusion.  This   •  BP                 •  Asymptomatic:  treatment  is  aimed  at
            leads to short-term stability but long-term   ○   Normal to low: systolic ≤ 100 mm Hg   prolonging the preclinical period.
            myocardial remodeling and enlargement     with myocardial failure    •  Symptomatic: treatment is aimed at reliev-
            (p. 408).                         •  Radiographs                       ing clinical symptoms associated with
           •  The  clinical  stages  of  symptomatic  DCM   ○   Thoracic: cardiomegaly, pulmonary venous   CHF (pulmonary edema and/or effusion),
            are characterized by two distinct outcomes:  distention, perihilar pulmonary edema, or   life-threatening ventricular arrhythmias, and
            ○   CHF: 1-year survival rate < 10%   pleural effusion                 significant supraventricular arrhythmias.

                                                     www.ExpertConsult.com
   577   578   579   580   581   582   583   584   585   586   587